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Interneurons comprise a minority of the striatal neuronal population of roughly 5%.
However, this heterogeneous population is of particular interest as it fulfills an important
relay function in modulating the output of the only type of striatal projection neurons,
i.e., the medium spiny neuron (MSN). One subtype of this heterogenous group, the
cholinergic interneuron, is of particular scientific interest as there is a relevant body of
evidence from animal models supporting its special significance in the disease process.
The development of protocols for directed differentiation of human pluripotent stem cells
(PSC) into striatal interneurons provides a unique opportunity to derive in vitro those cell
types that are most severely affected in dystonia. In this review we first aim to give a
concise overview about the normal function of striatal interneurons and their dysfunction in
dystonia in order to identify the most relevant interneuronal subtype for the pathogenesis
of dystonia. Secondly we demonstrate how knowledge about the embryonic development
of striatal interneurons is of particular help for the development of differentiation protocols
from PSC and by this depict potential ways of deriving in vitro disease models of dystonia.
We furthermore address the question as to whether cell replacement therapies might
represent a beneficial approach for the treatment of dystonia.
Keywords: striatal interneurons, development, dystonia, disease modeling, induced pluripotent neurons,
differentiation
INTRODUCTION
Dystonias are a heterogeneous group of movement disorders
characterized by sustained or intermittent muscle contractions
causing abnormal, often repetitive, movements, postures, or both.
Dystonic movements are typically patterned and twisting and may
be tremulous. Dystonia is often initiated or worsened by voluntary
action and associated with overflow muscle activation (Albanese
et al., 2013). Distribution of dystonia ranges from focal (one body
region), segmental (two or more adjacent regions) to generalized
forms (Geyer and Bressman, 2006). While complex dystonias arise
from either brain damage or pharmacological/toxicological alter-
ations, isolated dystonias have either no evident cause (previously
referred to as idiopathic dystonias) or are due to inherited or
spontaneous mutations in the genome (familial dystonias). In
contrast, combined dystonias show additional symptoms (such as
parkinsonism or myoclonus) in addition to the dystonia (Klein
et al., 2014). Isolated dystonias can be further substratified with
respect to body distribution into generalized, segmental, mul-
tifocal or focal forms. In the present review, we will focus on
generalized, isolated dystonia which usually starts in childhood
in a limb and progresses to generalize, however usually spares the
neck and face (Warner and Jarman, 1998).
Although Oppenheim already presumed an organic cause of
generalized dystonia in 1911 and even identified “hereditary
burden to play a major role” (Oppenheim, 1911; Klein and Fahn,
2013), the bizarre nature of some manifestations and the absence
of any structural abnormalities or degeneration in the isolated
dystonias led to the hypothesis of dystonia being an entirely psy-
chogenic group of disorders (Lanska, 2010). The first described
mutation for generalized isolated dystonia was a GAG deletion
in the Tor1a gene causing DYT-TOR1A (also known as DYT1)
(Ozelius et al., 1997). Although additional genes have been impli-
cated in generalized forms of dystonia in the meantime, DYT-
TOR1A accounts for roughly 40% of the generalized dystonias
(Valente et al., 1998) and reaches up to 90% in Ashkenazi Jews
due to a founder effect (Kramer et al., 1994).
The emergence of animal models of DYT-TOR1A shed some
light on the disease mechanism of dystonias and highlighted the
role of striatal cholinergic interneurons in this process (Pisani
et al., 2007). The advent of induced pluripotent stem cells (iPS)
as a source of patient-derived and patient-specific cell lines
(Takahashi et al., 2007; Park et al., 2008) also accelerated the devel-
opment of neural induction and differentiation protocols offer-
ing the potential to generate regional specified human neurons
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in vitro (Chambers et al., 2009; Crompton et al., 2013; Liu et al.,
2013b), paving the way for “disease in a dish” modeling.
Since no stem cell-derived in vitro model of dystonias has
become available to date, our main goal in this review is to provide
a potential “roadmap” for achieving this goal. The development of
stem cell-derived in vitro models of neurological diseases requires
a broad perspective including knowledge about the physiological
function and pathological dysfunction, as well as insight into the
embryogenesis of the affected cell type, since these serve the basis
for the successful generation of directed differentiation protocols
and their subsequent evaluation.
When it comes to modeling of diseases with iPS, the best
suited model for this purpose are inherited conditions which
are based on a known gene or mutations. Since all somatic
cells of the organism carry this mutation, so will the cells being
reprogrammed and the derived iPS. We will limit this review on
the best-characterized form of inherited dystonia, i.e., isolated
generalized DYT-TOR1A and will focus on findings from the cor-
responding animal model and the striatal cholinergic interneuron
as the cell type with the best documented functional alterations in
this context.
As another possibility of employing stem cell-derived striatal
interneurons, we will discuss whether cell replacement strategies
might represent a beneficial approach in treating certain sub-
groups of dystonia patients.
STRIATAL INTERNEURONS
The human striatum is composed of two morphologically but
not functionally distinct parts: the putamen and the caudate
ncl. It is an integral part of the basal ganglia and serves as a
relay station integrating glutamatergic input from the cortex and
thalamus and dopaminergic input from the substantia nigra for
selection, facilitation or suppression of action and movement
(Groenewegen, 2003). The majority of striatal neurons (95%)
are GABAergic projection neurons, the so called medium spiny
neurons (MSNs).
The remaining 5% of striatal neurons are formed by a het-
erogeneous population of interneurons that modulate the striatal
output of the MSN. At least five classes of interneurons can
be subdivided in the mammalian striatum based on size, neu-
rotransmitter, (immuno)cytochemical, and electrophysiological
properties (Kawaguchi, 1993): neurons of the first group are
medium-sized, GABAergic, express the calcium-binding protein
parvalbumin and show a fast spiking activity (FS). The second
group is also medium-sized and GABAergic; based on its elec-
trophysiological characteristics cells of this group are termed
persistent and low-threshold spike (PLTS) cells. They express the
neuropeptides somatostatin (SOM), neuropeptide Y (NPY) and
the nitric oxide synthase (NOS; Figueredo-Cardenas et al., 1996).
Interneurons of the third group are small- to medium-sized,
GABAergic, and express the calcium-binding protein calretinin
(Tepper et al., 2010). The fourth group contains the largest
cells of the striatum, which are, in contrast to all other striatal
neurons, cholinergic and show a long-lasting afterhyperpolar-
ization (LA) after excitation (Kawaguchi et al., 1995). The fifth
subtype is comprised of medium-sized neurons, which are also
GABAergic despite their positivity for tyrosine hydroxylase (TH),
electrophysiologically, the latter can be subdivided into at least
four subgroups (Ibáñez-Sandoval et al., 2010).
In contrast to other striatal cells, striatal cholinergic interneu-
rons show a spontaneous spiking acitivity, leading to the term
“tonically active neurons” (TAN; Bennett and Wilson, 1999).
In vivo recordings in primates demonstrated that salient stimuli
evoked a short bursting of these neurons followed by a pause in
firing, a response also elicited by conditioned stimuli after classical
conditioning (Aosaki et al., 1994). These findings were detailed by
in vitro recordings of acute rodent brain slices consisting of the
cortico-striatal and thalamo-striatal connections: glutamatergic
thalamo-striatal projections on cholinergic interneurons evoke
the burst-pause response which suppresses transiently cortico-
striatal projections on MSN, followed however by a phase of
enhanced responsiveness of MSNs to cortical inputs in terms of an
enhanced connectivity (Ding et al., 2010). It is therefore assumed
that those interneurons mediate a “stop and no-go” response
to salient stimuli followed by a redirection of attention. This
response is modulated by dopaminergic nigro-striatal projections
innervating the cholinergic interneurons by D2 receptors (D2R;
Reynolds et al., 2004; Smith and Villalba, 2008). As G-protein-
coupled receptors, D2R inhibit voltage-gated sodium channels
(NaV 1.1, 1.2 and 1.6) and reduce the spontaneous spiking activity
of cholinergic interneurons (Carr et al., 2003). They, however, also
act in an inhibitory manner on N-type CaV 2.2 calcium channels
that promote the opening of hyperpolarizing inward-rectifying
potassium channels (Kir3) (Goldberg and Wilson, 2005). Under
physiological conditions the resulting net effect of an activation
of D2R is a reduction of spiking activity (see Figure 1). For a
summary of the different interneuronal subtypes, see Table 1.
STRIATAL CHOLINERGIC INTERNEURONS IN DYT-TOR1A
In order to study isolated dystonias on an experimental basis,
appropriate animal models are needed. Animal models of dysto-
nia are manifold and can be divided into a toxic and a genetic
category: the genetic category better reproduces molecular and
neurophysiologic features, however, the motor phenotype is typ-
ically more subtle (for a complete review see Oleas et al., 2013;
Wilson and Hess, 2013). Although there are many known genes,
mutations in which lead to dystonia (Lohmann and Klein, 2013)
animal models are largely unavailable.
As mentioned above, DYT-TOR1A dystonia is caused by a
heterozygous 3-bp GAG deletion in the Tor1a gene (Ozelius et al.,
1997). The product of the gene (TorsinA) is as a member of the
AAA+ (ATPases associated with a variety of cellular activities)
protein family and fulfills a widespread role in vesicle trafficking
and serves as a chaperone in protein processing (Hanson and
Whiteheart, 2005). The deletion of GAG results in the loss of a
c-terminal glutamic acid residue and is thought to destabilize the
tertiary structure of the protein acting as to a loss-of-function
(Kock et al., 2006). Moreover mutant torsinA impairs the function
of wildtype protein and is therefore exerting a dominant negative
effect (Torres et al., 2004). The neuron-specific effect is believed
to be the result of a lack of other forms of torsins, notably torsinB
in neurons, that could compensate for the relative shortage of
functional torsin (Jungwirth et al., 2010). Certain levels of normal
torsinA are obviously crucial for the embryonic development
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FIGURE 1 | Overview of D2-receptor coupling in striatal cholinergic
interneurons. Under physiological conditions (upper panel) binding of
dopamine (DA) to D2 receptors (D2R) has an inhibitory effect on
voltage-activated sodium channels (NaV 1.1, 1.2 and 1.6), which depolarize the
cell membrane, and to N-type calcium channels (CaV 2.2), which activate
inward-rectifying sodium channels (Kir3) and hyperpolarize the cell membrane.
Although this represents two opposing effects, the net effect of D2R-activity
results in a reduction of spiking and the spontaneous firing rate. In the
presence of mutated TorsinA (mtTor1A) (lower panel), the inhibitory coupling
of D2R to CaV 2.2 is enhanced and the amount of currents through the N-type
channels in proportion to the total cellular calcium currents is increased
(represented by the changes in the pie charts). This shifts the net effect of
D2R towards enhanced activity of cholinergic interneurons. Whether mutant
TorsinA also affects the coupling of D2R to NaVs is currently unknown.
as complete knock-outs, but also combinations of knock-out of
wildtype and knock-in of mutant torsinA, resulting in neonatal
lethality (Goodchild et al., 2005; Yokoi et al., 2012).
Animal models for DYT-TOR1A have been established for
invertebrates (namely C. elegans and D. melanogaster) (Caldwell
et al., 2003; Koh et al., 2004; Cao et al., 2005) which are suitable
models for studying basic principles of the disease mechanisms
on a multi-cellular level. However, the vast differences to the
mammalian central nervous system limit the explanatory value
for complex neuronal networks.
More relevant in terms of understanding alterations in neu-
ronal networks in DYT-TOR1A are of course rodent models. Of
Table 1 | Overview of striatal interneurons.
No. Marker Neurotransmitter Size Electrophysiological properties Assumed function
1 PV GABA M Fast spiking activity (FS) Feed-forward inhibition from
cortical afferents to MSN
2 SOM/NPY/NOS GABA + M Persistent and low-threshold Modulation by release of
neuropeptides spike (PLTS) neuropeptides
3 CR GABA S Unknown Unknown
4 ChAT Ach L Tonically active Relaying thalamo-striatal and
neurons (TAN) cortico-striatal input, modulated by
nigrostriatal afferents
5 TH GABA M Heterogenous Modulating MSN
Acetylcholine (Ach), choline acetyl transferase (ChAT), calretinin (CR), large size (L), medium size (M), medium spiny neuron (MSN), neuropeptide Y (NPY), nitric oxide
synthase (NOS), parvalbumin (PV), small size (S), somatostatin (SOM), tyrosine hydroxylase (TH).
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these, the most relevant one is the Dyt1 ∆GAG, which consists
of a heterozygous GAG deletion in the murine TOR1A gene,
the same recurrent mutation observed in DYT-TOR1A patients.
Another group of models are brain region-specific knock-outs
of TOR1A based on the CRE-lox-system (Yokoi et al., 2008;
Sciamanna et al., 2012a). These models are particularly helpful
for studying the contribution of different cerebral regions to
the disease process. The third group is comprised of transgenic
models engineered to overexpress human mutant or wildtype
torsinA driven by different promoters, such as the neuron-specific
enolase (NSE; Shashidharan et al., 2005) or the constitutively
active human cytomegalovirus (hCMV) promoter (Sharma et al.,
2005). However, the results of this latter group of models need
to be interpreted with care as observed effects could also be
attributed to ectopic expression or unphysiologically high levels
of torsinA.
A particular motor phenotype was found in the mouse model
expressing the human mutated TOR1A gene under control of the
NSE promoter (Shashidharan et al., 2005): transgenic animals
showed enhanced motor activity in the open field test which
increased significantly over time, and some animals displayed
an abnormal shaking of the head from one side to the other
or even tonic lateralized deviations of it. Another feature was
“self clasping” of the limbs when hung from the tail. Admittedly,
this phenotype differs from the pronounced generalized dystonia
known from patients suffering from DYT-TOR1A, however, it
must be kept in mind that—as we learned from other transgenic
models of neurodegenerative diseases (like the transgenic models
of Huntington’s disease (Figiel et al., 2012))—motor abnormal-
ities in rodents often differ considerably from those seen in
humans.
Despite these drawbacks, animal models have helped to iden-
tify alterations in neuronal networks possibly leading to dystonia.
Their value was further emphasized by the fact that a reduction
of the dopamine-binding capacity of striatal type 2 dopamine-
receptors (D2R; Dang et al., 2012), as well as alterations in the
cerebellothalamocortical pathways could be observed (Ulug˘ et al.,
2011), findings already known from human mutation carriers
(Asanuma et al., 2005; Carbon et al., 2010a,b). The transgenic
knock-in models have been extensively characterized on an elec-
trophysiological level and broadened our understanding of the
neuronal network alterations potentially leading to dystonia: for
example, recordings of MSNs in mice overexpressing mutant
human torsinA showed a pronounced alteration of glutamater-
gic synaptic transmission. While a long-term depression (LTD)
could not be elicited, long-term potentiation (LTP) was more
pronounced and synaptic depotentiation (SD) to low-frequency
stimuli (LFS) could not be evoked (Martella et al., 2009). These
alterations could be reverted by either lowering acetylcholine
levels or antagonizing muscarinic receptors of the M1-type link-
ing these changes to altered cholinergic transmission. Recordings
of striatal cholinergic interneurons did indeed reveal an altered
response to thalamic stimulation, as the evoked burst-pause
response was significantly shorter and followed by an abnormal
spiking activity (Sciamanna et al., 2012b). As the pause response
is a D2R-dependent process (Goldberg and Reynolds, 2011), a link
between the already mentioned altered dopaminergic response
in DYT-TOR1A and this phenomenon seems likely. Accordingly,
a profound alteration of the D2R-mediated response could be
demonstrated in striatal cholinergic interneurons, as their acti-
vation caused a paradoxical excitation instead the expected inhi-
bition (Pisani et al., 2006). The cause of this alteration is an
enhanced inhibitory coupling of D2R to the previously men-
tioned N-type Cav 2.2 channels and an increased proportion of
their currents to the overall cellular calcium currents, leading to
a rise in spiking activity (Figure 1). The cause of this enhanced
inhibitory coupling is at the moment unclear, however, it is tempt-
ing to speculate that the regulator of G-protein signaling 9–2 (RGS
9–2), which was shown to modulate the coupling between D2R
and Cav 2.2, might play a role in this regard. However, this does
not answer the question whether the inhibitory coupling to the
voltage-gated sodium channels (which should counterbalance this
effect) is not enhanced (Cabrera-Vera et al., 2004). In addition,
these results need to be interpreted with caution as the ubiquitous
over expression of mutant torsinA in this model does not closely
correspond to the actual situation in DYT-TOR1A. However,
these findings were reproduced in a mouse model with a targeted
deletion of TOR1A in cholinergic interneurons, supporting the
findings that mutant torsinA exerts a dominant-negative effect on
wildtype torsinA (Sciamanna et al., 2012a).
The key point is, however, how these findings explain the
occurrence of the dystonic movement disorder? Current models
of basal ganglia function are based on the presence of parallel dis-
tinct loops connecting the cortex with different parts of the basal
ganglia and thus facilitating wanted and suppressing unwanted
movement. In contrast, dystonia results from a co-contraction of
muscle groups usually not activated during a particular task, a
phenomenon termed “dystonic overflow” (Mink, 2003). As the
striatum plays an important role in the basal ganglia circuitry, it is
tempting to speculate that enhanced LTP and reduced LTD based
on an increased cholinergic tone in dystonia favors the promo-
tion of aberrant and contradicting motor commands (Sciamanna
et al., 2012b), however, more experimental data will be needed to
further clarify this matter.
While the role of GABAergic interneurons in DYT1 has not
yet been studied in depth, one study found altered intracellular
calcium dynamics in heterozygous ∆E-torsinA knock-in mice
leading to a higher excitability of those cells (Iwabuchi et al.,
2013).
EMBRYONAL DEVELOPMENT OF STRIATAL INTERNEURONS
The striatum (caudate nucleus and pallidum) develops from the
lateral (LGE) and medial ganglionic eminence (MGE) located
in the basal part of the telecephalon. While striatal projection
neurons (namely MSN) arise from the lateral ganglionic emi-
nence (Deacon et al., 1994), almost all striatal interneurons as
well as cortical interneurons, cholinergic basal forebrain pro-
jection neurons, projection neurons of the globus pallidus, and
telencephalic oligodendrocytes are generated in the MGE and
reach their final destination either by migrating tangentially
or radially (Anderson et al., 1999; Marin et al., 2000; Kessaris
et al., 2006). The ventricular zone (VZ) of the MGE comprises
neural progenitors expressing the NKX2.1 homeodomain pro-
tein, required for their specification (Butt et al., 2008), their
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patterning being in turn dependent on the morphogen sonic
hedgehog (SHH; Xu et al., 2010). After exiting the cell cycle,
postmitotic NKX2.1+ progenitors start migrating out of the MGE
and express the LIM-homeodomain-transcription factor LHX6
(Du et al., 2008). This process is dependent on the transcrip-
tion factors DLX1/2 and MASH1 (Marin et al., 2000). These
immature neurons also contain GABA and share certain func-
tional characteristics with mature GABAergic neurons, however,
lack other molecular markers of specified interneuronal popu-
lations (like PV, SOM, NOS), so that they are termed proto-
GABAergic (Flames and Marín, 2005). These cells are bipotential
precursors being able to terminally differentiate either into the
GABAergic or cholinergic lineage. Terminal differentiation into
GABAergic interneurons is dependent on sustained expression
of LHX6 and thus representing a sort of “default” maturation
pathway (Liodis et al., 2007; Zhao et al., 2008). Differentiation
into the cholinergic lineage requires expression of LHX7 (also
known as L3/LHX8) which induces expression of another LIM-
homeodomain-transcription factor islet-1 (ISL1), which directly
downregulates LHX6 expression (Fragkouli et al., 2009). Interest-
ingly, the cholinergic phenotype remains dependent on ongoing
LHX7 expression even in postmitotically committed cholinergic
neurons, as deletion of the LHX7 gene leads to a switch of
phenotype to GABAergic interneurons (Lopes et al., 2012). The
processes described above are summarized in Figure 2.
DERIVING STRIATAL INTERNEURONS FROM
PLURIPOTENT STEM CELLS
Although animal models have been of great help in elucidating
altered cellular mechanisms in dystonia and will most likely
remain unsurpassed when it comes to the study of complex neural
networks, obtaining human neurons is highly desirable in order to
confirm findings from animal models or gaining new insights into
mechanisms of the human basal ganglia. Pluripotent stem cells
(PSC) can be differentiated into cells of the entire body, including
neurons. iPS even allow generating patient-specific cells, sharing
all possible genetic deviations and variants of the donor patient
(Yamanaka, 2009).
In order to obtain a neuronal population enriched for a desired
regional phenotype, it is necessary to recapitulate the in vivo
developmental processes under in vitro conditions.
Patterning primitive neuroectoderm or neuroepithelial pre-
cursors in order to obtain a desired regional phenotype requires
the presence of morphogens mediating the expression of down-
stream effectors, the most important in this respect being SHH,
fibroblast growth factors (FGFs), bone morphogenetic proteins
(BMPs), and agonists of the wingless/Int-1 pathway (WNT;
Hébert and Fishell, 2008; Sousa and Fishell, 2010; Cho et al.,
2013). Patterning neural cells in vitro requires the addition of
morphogens in a timed manner and at appropriate concentra-
tions. Since almost all forebrain interneurons arise from the MGE
in the ventral forebrain, the addition of morphogens required
for ventral forebrain specification to the cell culture should
promote a corresponding phenotype. Accordingly, all published
protocols utilize the strong ventralizing activity of SHH or its
small molecule agonists (Bissonnette et al., 2011; Crompton et al.,
2013; Germain et al., 2013; Liu et al., 2013a,b; Nicholas et al.,
2013; Duan et al., 2014). In this respect, a dose dependency
was demonstrated, as increasing the dose of SHH increased
the number of NKX 2.1+ MGE-progenitors with doses ranging
up to 1000 ng/ml (Li et al., 2009; Liu et al., 2013b). Another
common component for MGE patterning is FGF8 due to its
important role in ventral forebrain patterning (Storm et al., 2006).
Although many published protocols include FGF8 (Bissonnette
et al., 2011; Danjo et al., 2011), there are also reports omit-
ting FGF8. As SHH concentrations used are higher in these
protocols, it can be speculated that FGF8 can be replaced by
high SHH concentrations (Liu et al., 2013a,b). The canonical
WNT/β-catenin-pathway plays an important role in forebrain
patterning both on the rostro-caudal- and ventro-dorsal axis:
patterning of the dorsal telencephalon depends on activation of
canonical WNT signaling (Backman et al., 2005). Conversely,
cells of the ventrally localized VZ express the dickkopf proteins
(a family of WNT-antagonists) (DKK; Diep et al., 2004) and
combined SHH and DKK1 exposure enhances ventral telen-
cephalic identity (Li et al., 2009; Nicoleau et al., 2013). Many
protocols achieving successful MGE patterning however do not
employ WNT modulation. A potential reason for this could
be the fact that DKK alone has no pronounced ventralizing
effect but rather potentiates SHH activity (Li et al., 2009), so
that high levels of SHH alone could also be sufficient. The
pronounced rostralizing effect of DKK1 (Caneparo et al., 2007)
is obviously not necessary for successful patterning of in vitro
ventral-forebrain patterning, since neural induction of PSCs
leads to an anterior-dorsal identity by default (Pankratz et al.,
2007).
Under optimal conditions, over 90% of the cells express NKX
2.1, thereby demonstrates MGE identity. These neurons are 45%
cholinergic and 55% GABAergic (Liu et al., 2013b). This under-
lines the general fact that in vitro patterning can indeed specify the
regional identity of cells in a highly effective manner, however, full
specification to a single cell type (e.g., solely cholinergic) cannot
be achieved in this way. One more recent protocol reported
achievement of 94% forebrain cholinergic interneurons by tran-
sient overexpression of GBX1 and LHX7 (L3/LHX8) (Bissonnette
et al., 2011). This example demonstrates how knowledge of
molecular pathways in neural differentiation can help increase the
specificity of directed differentiation beyond the scope of regional
patterning.
RATIONALE FOR CELL REPLACEMENT STRATEGIES
IN DYSTONIA
Cell replacement strategies as potential treatment for
neurodegenerative disorders have been carried out for a couple
of decades with promising results in animal models but mixed
outcome in clinical trials (Bjorklund and Kordower, 2013; Kim
et al., 2013; Lindvall, 2013). While replacing a subpopulation of
neurons seems at least in theory a feasible approach for treating
neurodegenerative disorders, isolated dystonias as the DYT-
TOR1A lack an overt cell loss. Accordingly, there are no reports
of neural cell transplantation approaches in the current literature.
Assuming the area of application for neural cell transplantation
is neurodegenerative disorders with predominant affection of a
confined cell type, isolated dystonias do obviously not qualify for
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FIGURE 2 | Overview of the molecular processes involved in the
specification of MGE-derived forebrain interneurons (adapted from
Fragkouli et al., 2009). Forebrain interneurons are derived from
NKX2.1+ proliferative progenitors located in the ventricular zone (VZ) of
the MGE. Once they exit the cell cycle they move to the
subventricular zone (SVZ) and start expressing LHX6. As they contain
GABA, they are termed “proto-GABAergic”. When LHX6 expression is
maintained, they either continue to express NKX2.1 and differentiate
towards striatal GABAergic interneurons. Alternatively, the zinc finger
homeobox gene Zfhx1b, which acts downstream of DLX1/2, represses
NKX2.1 expression, in which case cortical GABAergic interneurons arise.
Through ISL1, LHX7 expression leads to a repression of LHX6 and
thus differentiation towards cholinergic neurons positive for choline
acetyl transferase (ChAT).
such an approach due to the lack of neurodegeneration. On the
other hand, complex dystonias frequently show too widespread
a damage (Klein et al., 2014). Possibly the only potentially
promising predominantly dystonic movement disorder is the
combined dystonia DYT-TAF1 (X-linked dystonia parkinsonism
= XDP). This disease is characterized by an adult-onset initial
phase of generalized dystonia with oromandibular predominance,
followed by a second predominantly hypokinetic-rigid phase
(Klein et al., 2014). This disease is caused by a pronounced
degeneration of MSNs inside the striosome compartment in the
first stage of the disease, followed by a degeneration of MSNs
inside the matrix compartment during the second phase, while
relatively sparing the striatal interneurons (Goto et al., 2005; Kaji
et al., 2005). Therefore, a possible neurorestaurative approach to
DYT-TAF1 would indeed be the transplantation of precursors for
MSNs out of the LGE, similarly as in Huntington’s disease.
CONCLUSIONS
The absence of neurodegeneration identifies isolated dystonias as
neuronal network diseases. Interneurons representing roughly 5%
of the striatal neural population play an important role in mod-
ifying the output of the MSN as projection neurons and relaying
thalamo-striatal and cortico-striatal inputs, especially cholinergic
interneurons play an important role in integrating sensory input
and redirecting attention. Using the example of DYT-TOR1A as
the best studied form of isolated dystonia, we present the current
knowledge as to how striatal cholinergic interneurons may play
a central role in the pathophysiology of dystonia through an
altered response to dopaminergic input leading to overactivity
and dysfunctional gating of thalamostriatal input.
We summarized the origins and developmental processes
of forebrain interneurons in combination with the molecular
mechanisms that switch between GABAergic and cholinergic
phenotypes.
We demonstrated on the basis of recent protocols, how
knowledge of the developmental mechanisms can be employed
for directed neural differentiation of PSC in order to obtain
human forebrain interneurons in vitro. Although to date no
published study employed PSC-derived striatal interneurons in
order to study dystonia, this technique holds great potential for
deciphering the underlying disease mechanisms of dystonia, as
the necessary protocols have already been published and just
await their application for in vitro modeling of DYT-TOR1A.
We finally discuss potential neurorestaurative approaches for
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different subtypes of dystonias: while isolated dystonias most
likely are no suitable candidates for this procedure due to the
lack of neurodegeneration and complex dystonias are commonly
characterized by too widespread a neural damage, transplantation
of MSN precursors could be a potential field of application in
XDP or DYT-TAF1 with its relatively confined degeneration of
striosomes.
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